Natraj Proteins Intrinsic Value
Natraj Proteins intrinsic value. Natraj Proteins (NATRAJPR) median intrinsic value is ₹91.17 from 9 valuation models (range ₹73–₹109), vs current price ₹36.47 — +150.0% upside (Trading Below Calculated Value), margin of safety 60.0%. Compare with NATRAJPR fundamental valuation to assess whether the stock is under or overvalued.
NATRAJPR Valuation Methods Summary — DCF, Graham Number & P/E
Natraj Proteins intrinsic value across 9 models vs current price ₹36.47 — upside/downside and value range per method. Read NATRAJPR dividend history for the complete payout history and dividend yield track record.
| Method | Type | Intrinsic Value | Range | Upside/Downside | Details |
|---|---|---|---|---|---|
| P/E Based Valuation | earnings | ₹109.41 | ₹87.53 - ₹131.29 | +200.0% | EPS: ₹11.90, Sector P/E: 12x |
| Book Value Method | asset | ₹82.50 | ₹74.25 - ₹90.75 | +126.2% | Book Value/Share: ₹82.50, P/B: 1.0x |
| Revenue Multiple Method | revenue | ₹72.94 | ₹65.65 - ₹80.23 | +100.0% | Revenue/Share: ₹265.00, P/S: 0.8x |
| EBITDA Multiple Method | earnings | ₹72.94 | ₹65.65 - ₹80.23 | +100.0% | EBITDA: ₹7.00Cr, EV/EBITDA: 6x |
| Simple DCF (5Y) | dcf | ₹91.17 | ₹72.94 - ₹109.40 | +150.0% | CF Growth: 15.0%, Discount: 15% |
| PEG Ratio Method | growth | ₹109.41 | ₹98.47 - ₹120.35 | +200.0% | EPS Growth: 20.0%, Fair P/E: 16.0x |
| Growth Adjusted P/E | growth | ₹95.20 | ₹85.68 - ₹104.72 | +161.0% | Revenue Growth: -7.4%, Adj P/E: 8.0x |
| ROE Based Valuation | profitability | ₹72.94 | ₹65.65 - ₹80.23 | +100.0% | ROE: 15.2%, P/E Multiple: 14x |
| Graham Defensive Method | conservative | ₹109.41 | ₹98.47 - ₹120.35 | +200.0% | EPS: ₹11.90, BVPS: ₹82.50 |
NATRAJPR Intrinsic Value vs Market Price — All Valuation Models
Natraj Proteins fair value range ₹73–₹109 vs current market price ₹36.47 across 9 valuation models. For current market price and key ratios, visit NATRAJPR screener.
NATRAJPR Intrinsic Value Analysis — Undervalued or Overvalued?
Natraj Proteins median intrinsic value ₹91.17, current price ₹36.47 — Trading Below Calculated Value by 150.0%, margin of safety 60.0%.
What is the intrinsic value of NATRAJPR?
Based on our comprehensive analysis using 9 different valuation methods, the estimated intrinsic value of Natraj Proteins (NATRAJPR) is ₹91.17 (median value). With the current market price of ₹36.47, this represents a +150.0% variance from our estimated fair value.
The valuation range spans from ₹72.94 to ₹109.41, indicating ₹72.94 - ₹109.41.
Is NATRAJPR undervalued or overvalued?
Based on our multi-method analysis, Natraj Proteins (NATRAJPR) appears to be trading below calculated value by approximately 150.0%.
NATRAJPR Financial Health — Key Ratios vs Industry Benchmarks
Natraj Proteins financial ratios — ROE, debt-to-equity, profit margins and liquidity vs industry benchmarks and their impact on intrinsic value.
| Financial Metric | Current Value | Industry Benchmark | Assessment | Impact on Valuation |
|---|---|---|---|---|
| Current Ratio | 61.00 | Industry Standard: 2.0+ | Above 2.0 | Measures short-term liquidity capacity |
| Return on Equity | 15.2% | Industry Standard: 15%+ | Above 15% | Measures shareholder return efficiency |
| Operating Margin | 7.0% | Industry Standard: 20%+ | Below 10% | Indicates operational efficiency level |
| Asset Turnover Ratio | 1.39x | Industry Standard: 1.0x+ | Above 1.0x | Measures asset utilization efficiency |
NATRAJPR Cash Flow Quality — Operating & Free Cash Flow
Natraj Proteins operating cash flow, free cash flow, quality rating and sustainability score by period — key inputs to DCF intrinsic value calculation.
| Period | Operating Cash Flow | Free Cash Flow | Cash Flow Quality | Sustainability Score |
|---|---|---|---|---|
| March 2026 | ₹-14 Cr | ₹-14 Cr | Negative Cash Flow | 3/10 |
| March 2025 | ₹22 Cr | ₹21 Cr | Positive Free Cash Flow | 8/10 |
| March 2024 | ₹-6 Cr | ₹-6 Cr | Negative Cash Flow | 3/10 |
| March 2023 | ₹3 Cr | ₹2 Cr | Positive Free Cash Flow | 7/10 |
| March 2022 | ₹6 Cr | ₹5 Cr | Positive Free Cash Flow | 8/10 |